Abstract:The discovery of the gut–brain axis has proven that brain functions can be affected by the gut microbiota's metabolites, so there are significant opportunities to explore new tools to regulate gut microbiota and thus work on the brain functions. Meanwhile, engineered bacteria as oral live biotherapeutic agents to regulate the host's healthy homeostasis have attracted much attention in microbial therapy. However, whether this strategy is able to remotely regulate the host's brain function in vivo has not been investigated. Here, we engineered three blue-light-responsive probiotics as oral live biotherapeutic agents. They are spatiotemporally delivered and controlled by the upconversion optogenetic micro–nano system. This micro–nano system promotes the small intestine targeting and production of the exogenous L. lactis in the intestines, which realizes precise manipulation of brain functions including anxiety behavior, Parkinson's disease, and vagal afferent. The noninvasive and real-time probiotic intervention strategy makes the communiation from the gut to the host more controllable, which will enable the potential for engineered microbes accurately and effectively regulating a host's health.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsnano.1c11536.(Figure S1) Growth curve of L. lactis NZ9000 upon glucose, reversibility of pDawn module-guided GFP expression upon blue light illumination, fluorescence images of the sodium alginate microsphere, and small intestine bacteria counts from mice treated by oral gavage or microsphere delivery method; (Figure S2) transmission electron microscope (TEM) image of blue light-emitting UCRs, scanning electron microscope (SEM) images of UCM; (Figure S3) stability of UCM at various times and pH or upon NIR light illumination; (Figure S4) reversibility of GFP expression from LL-GFP upon UCM+NIR light illumination and growth curve of L. lactis NZ9000 upon 475 nm blue light or 980 nm NIR light irradiation; (Figure S5) UCM stability in vivo; (Figure S6) biosafety and colocalization of bacteria and UCM in vivo; (Figure S7) GABA bioactivity test by acid tolerance assay and serum GABA content upon various treatments; (Figure S8) EPM and OPT tests of anxiety mice with various treatments; (Figure S9) GABA receptor (GABAR) detection in the brain extraction, PCR detection of fecal samples, and GABA content in the serum; (Figure S10) EPM and OPT test on day 2 of LL-GABA+UCM+NIR light treatment; (Figure S11) expression of LL-GCSF-Flag in vitro and in vivo, Western blot testing of GCSF produced by LL-GCSF-Flag; (Figure S12) schematics and test of Y maze; (Figure S13) inflammatory factor IL-2, IL-6, and TNF-α levels in the brain of various treated PD model mice; (Figure S14) abundance analysis of microbes in feces at genus level between control and LL-GCSF treated mice, PCR detection of fecal samples, and GCSF content in the serum; (Figure S15) Western blot detection of GLP1 produced by LL-GLP1-His, GLP1 bioactivity test, in vivo electrophysiological recordings of NTS in mice with various treatments, connection of the vagus nerve and the intestine, and c-Fos-positive cells in brainstem of mice treated with LL-GABA; (Figure S16) schematic diagram for preparing UCM; (Figure S17) application of the UCM+NIR light system in vitro or in vivo; (Table S1) all primers used in this study; (Table S2) detailed sequences for constructed plasmids in this study (PDF)This article has not yet been cited by other publications.

Luminescent ingestible electronic capsules for in vivo regulation of optogenetic engineered bacteria

A micro-nano optogenetic system based on probiotics for in situ host metabolism regulation

A Microbial-Electronic Optical Communication Language for Intestinal Monitoring and Regulation

Establishing remote communication between human operator and engineered intestinal microbe via bio-electronic optical language

Light-Sensitive <i>Lactococcus lactis</i> for Microbe-Gut-Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System

Optogenetic operated probiotics to regulate host metabolism by mimicking enteroendocrine

Site-specific incorporation of photo-cross-linker and bioorthogonal amino acids into enteric bacterial pathogens.

A red light-controlled probiotic bio-system for in-situ gut-brain axis regulation

Wirelessly-Powered Ingestible Electronic Capsule for Non-invasive Gastrointestinal Optogenetics

Light-Sensitive Lactococcus lactis for Microbe–Gut–Brain Axis Regulating via Upconversion Optogenetic Micro-Nano System

Upconversion optogenetic micro-nanosystem optically controls the secretion of light-responsive bacteria for systemic immunity regulation

NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut

Remote optogenetic control of the enteric nervous system and brain-gut axis in freely-behaving mice enabled by a wireless, battery-free optoelectronic device

Sub-1.4 cm3 capsule for detecting labile inflammatory biomarkers in situ

Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy.

Optogenetic Engineering to Probe the Molecular Choreography of STIM1-mediated Cell Signaling

Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice

Smart Capsule for Targeted Detection of Inflammation Levels Inside the GI Tract

Macroencapsulated Bacteria for in Vivo Sensing and Therapeutics

Optogenetic control of the enteric nervous system and gastrointestinal transit

Engineering Escherichia coli for Light-Activated Cytolysis of Mammalian Cells